Prime Medicine, Inc. (PRME) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $4.53M | -37.9% |
| 2024 | $7.29M | -16.4% |
| 2023 | $8.72M | -45.8% |
| 2022 | $16.09M | +287.8% |
| 2021 | $4.15M | +549.5% |
| 2020 | $639.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $4.53M | -37.9% |
| 2024 | $7.29M | -16.4% |
| 2023 | $8.72M | -45.8% |
| 2022 | $16.09M | +287.8% |
| 2021 | $4.15M | +549.5% |
| 2020 | $639.0K | — |